Ironwood vs. Bausch Health: Which GI Drug Stock is a Better Pick Now?Zacks Investment Research • 02/20/26
Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2025 Investor Update CallBusiness Wire • 02/18/26
IRWD Rises 307% in 6 Months: Is This an Indication to Buy the Stock?Zacks Investment Research • 02/12/26
Does Ironwood's Bullish 2026 View Signal Greater Linzess Adoption?Zacks Investment Research • 02/05/26
Ironwood Pharmaceuticals Maintains FY 2025 Financial Guidance and Announces FY 2026 Financial GuidanceBusiness Wire • 01/02/26
Ironwood Pharmaceuticals: Today's Gains Seem Sustainable After Disastrous First Half Of 2025Seeking Alpha • 11/26/25
IRWD Rises 110% in a Month: Should You Buy, Sell or Hold the Stock?Zacks Investment Research • 11/13/25
IRWD Beats on Q3 Earnings & Revenues, Raises 2025 View, Stock SoarsZacks Investment Research • 11/11/25
Ironwood Pharmaceuticals (IRWD) Q3 Earnings and Revenues Surpass EstimatesZacks Investment Research • 11/10/25
Ironwood Pharmaceuticals Reports Strong Third Quarter 2025 Results; Raises Full Year 2025 Financial GuidanceBusiness Wire • 11/10/25
Ironwood Stair & Rail Inc. Recognised With 2025 Consumer Choice Award for Stairs and Railings in Southern AlbertaAccesswire • 10/24/25
Why Ironwood Pharmaceuticals (IRWD) is a Top Momentum Stock for the Long-TermZacks Investment Research • 10/14/25
Ironwood Pharmaceuticals (IRWD) Beats Q2 Earnings and Revenue EstimatesZacks Investment Research • 08/07/25
Ironwood Pharmaceuticals Reports Second Quarter 2025 Results; Maintains Full Year 2025 Financial GuidanceBusiness Wire • 08/07/25